These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38889288)

  • 1. Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study.
    Bass AR; Xie F; Jannat-Khah D; Ghosh N; Chan KK; Saxena A; Curtis JR
    Rheumatology (Oxford); 2024 Jun; ():. PubMed ID: 38889288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid identification of inflammatory arthritis and associated adverse events following immune checkpoint therapy: a machine learning approach.
    Tran SD; Lin J; Galvez C; Rasmussen LV; Pacheco J; Perottino GM; Rahbari KJ; Miller CD; John JD; Theros J; Vogel K; Dinh PV; Malik S; Ramzan U; Tegtmeyer K; Mohindra N; Johnson JL; Luo Y; Kho A; Sosman J; Walunas TL
    Front Immunol; 2024; 15():1331959. PubMed ID: 38558818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen.
    Cappelli LC; Brahmer JR; Forde PM; Le DT; Lipson EJ; Naidoo J; Zheng L; Bingham CO; Shah AA
    Semin Arthritis Rheum; 2018 Dec; 48(3):553-557. PubMed ID: 29573850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation.
    Braaten TJ; Brahmer JR; Forde PM; Le D; Lipson EJ; Naidoo J; Schollenberger M; Zheng L; Bingham CO; Shah AA; Cappelli LC
    Ann Rheum Dis; 2020 Mar; 79(3):332-338. PubMed ID: 31540935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps.
    Cappelli LC; Grieb SM; Shah AA; Bingham CO; Orbai AM
    BMC Rheumatol; 2020; 4():32. PubMed ID: 32766511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience.
    Mooradian MJ; Nasrallah M; Gainor JF; Reynolds KL; Cohen JV; Lawrence DP; Miloslavsky EM; Kohler MJ; Sullivan RJ; Schoenfeld SR
    Semin Arthritis Rheum; 2019 Jun; 48(6):1127-1132. PubMed ID: 30409415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study.
    Gómez-Puerta JA; Lobo-Prat D; Perez-García C; Ponce A; Frade-Sosa B; Millán Arciniegas AM; Ojeda F; Ruiz-Esquide V; Corominas H
    Front Med (Lausanne); 2022; 9():888377. PubMed ID: 35783644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study.
    Ladouceur A; Barnetche T; Mouterde G; Tison A; Bitoun S; Prey S; Dutriaux C; Gerard E; Pham-Ledard A; Beylot-Barry M; Zysman M; Veillon R; Domblides C; Daste A; Gross-Goupil M; Sionneau B; Lefort F; Larroquette M; Richez C; Truchetet ME; Schaeverbeke T; Kostine M
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 38030233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer.
    Khorana AA; Palaia J; Rosenblatt L; Pisupati R; Huang N; Nguyen C; Barron J; Gallagher K; Bond TC
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.
    Jang SR; Nikita N; Banks J; Keith SW; Johnson JM; Wilson M; Lu-Yao G
    JAMA Netw Open; 2021 Dec; 4(12):e2136823. PubMed ID: 34854905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Increase of Circulating Transitional B Cells and Autoantibodies to Joint-Related Proteins in Patients With Metastatic Melanoma Developing Checkpoint Inhibitor-Induced Inflammatory Arthritis.
    Gatto M; Bjursten S; Jonsson CA; Agelii ML; Jonell C; McGrath S; Lönnblom E; Sareila O; Holmdahl R; Rudin A; Levin M; Gjertsson I
    Arthritis Rheumatol; 2023 May; 75(5):856-863. PubMed ID: 36409578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study.
    Reid P; Liew DF; Akruwala R; Bass AR; Chan KK
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34526389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management.
    Singh N; Shahane A; Sparks JA; Bitoun S; Cappelli LC
    Rheum Dis Clin North Am; 2024 May; 50(2):269-279. PubMed ID: 38670725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
    McCarter KR; Arabelovic S; Wang X; Wolfgang T; Yoshida K; Qian G; Kowalski EN; Vanni KMM; LeBoeuf NR; Buchbinder EI; Gedmintas L; MacFarlane LA; Rao DA; Shadick NA; Gravallese EM; Sparks JA
    Semin Arthritis Rheum; 2024 Feb; 64():152335. PubMed ID: 38100899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy.
    Jensen AK; Chatzidionysiou K; Torp CK; Sørensen AS; Tenstad HB; Schäfer VS; Kostine M; Jacobsen S; Leipe J; Kragstrup TW
    Biomed Pharmacother; 2022 Apr; 148():112687. PubMed ID: 35228067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy.
    Anjohrin S; Sheahan A; Suruki R; Stark JL; Sloan VS
    Rheumatol Ther; 2021 Dec; 8(4):1651-1659. PubMed ID: 34491550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis.
    Cappelli LC; Bingham CO; Forde PM; Anagnostou V; Brahmer J; Lipson EJ; Mammen J; Schollenberger M; Shah AA; Darrah E
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36096522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults.
    Schonfeld SJ; Tucker MA; Engels EA; Dores GM; Sampson JN; Shiels MS; Chanock SJ; Morton LM
    JAMA Netw Open; 2022 Mar; 5(3):e223461. PubMed ID: 35315916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
    Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
    Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States.
    Jain P; Gutierrez Bugarin J; Guha A; Jain C; Patil N; Shen T; Stanevich I; Nikore V; Margolin K; Ernstoff M; Velcheti V; Barnholtz-Sloan J; Dowlati A
    ESMO Open; 2021 Oct; 6(5):100252. PubMed ID: 34461483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.